The PE ratio for Encompass Health stock stands at 21.23 as of Oct 2, 2023. This results from the current EPS of $3.14 and stock price of $66.65. An increase of 6% has been seen in the P/E ratio compared to the average of 20.0 of the last 4 quarters.
Over the last ten years, the average PE ratio of Encompass Health has been 18.99. The current 21.23 PE ratio is 12% above the historical average. Over the past ten years, EHC's PE ratio was at its highest in the Dec 2020 quarter at 28.81, with a price of $82.69 and an EPS of $2.87. The Dec 2013 quarter recorded the bottom point at 12.91, with a price of $33.32 and an EPS of $2.58.
Maximum annual increase: 51.79% in 2020
Maximum annual decrease: -45.4% in 2021
EHC's current P/E ratio is above the 3, 5 and 10-year historical averages.
EHC's PE ratio is higher than its peer stock SEM.
|Stock name||PE ratio||Market cap|
|SEM Select Medical Holdings Corp||15.38||$3.13B|
|EHC Encompass Health Corp||21||$6.61B|
|NVOS Novo Integrated Sciences Inc||N/A||$46.98M|
As of Oct 2, 2023, EHC stock has a price to earnings ratio of 21.23.
The average PE ratio for EHC stock over the past 3 years is 20.43.
The average PE ratio for EHC stock over the past 5 years is 20.33.
In the last ten years, the Dec 2020 quarter recorded the highest quarterly PE ratio at 28.81.
EHC's price to earnings ratio is currently 12% above its 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Oct 2, 2023), Encompass Health's stock price is $66.65. The earnings per share for the trailing twelve months (TTM) ending Jun 2023 is $3.14. Therefore, Encompass Health's P/E ratio for today is 21.23.
PE RATIO(21.23) = STOCK PRICE($66.65) / TTM EPS($3.14)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.